Medtronic PLC (LTS:0Y6X)
$ 81.63 1.13 (1.41%) Market Cap: 104.56 Bil Enterprise Value: 125.12 Bil PE Ratio: 25.24 PB Ratio: 2.18 GF Score: 78/100

Medtronic PLC - Investor and Analyst Briefing from ADA in San Francisco Transcript

Jun 09, 2019 / 06:00PM GMT
Ryan Weispfenning
Medtronic plc - VP of IR

Okay. Good morning. I am Ryan Weispfenning, Vice President of Investor Relations at Medtronic. Thanks for coming to our diabetes investor briefing here at the American Diabetes Association conference here in San Francisco, and welcome to those joining us around the world on our webcast.

So before we get started, I want to note that we could make some comments that may be considered forward-looking statements, and actual results might differ materially from those projected in any forward-looking statement. Additional information concerning factors that could cause actual results to differ is contained in the periodic reports and other filings that we make with the SEC, and we do not undertake to update any forward-looking statement. I encourage you to go back and read the slide, which is #3 for those that are listening on the webcast. And the slides we are presenting today, along with our non-GAAP reconciliations, are available on our website at investorrelations.medtronic.com

So today's webcasted event will last about an hour. Omar Ishrak, our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot